Airway diseases
Respiratory critical care
Sleep and breathing disorders
Thematic poster
Asthma: outcomes of clinical trials and cohorts
Methods :
Epidemiology, General respiratory patient care, Cell and molecular biology
Chairs
S. Fowler
Preston (Lancashire)
(United Kingdom)
Management of asthma during pregnancy by consultant allergists: care is still not in consonance with clinical practice guidelines
K. Bregvadze(Tbilisi, Georgia)
COI
1
A preliminary study to determine the effects of nebulised salbutamol on blood glucose levels during an acute asthma exacerbation.
C. Mortimer(Sevenoaks (Kent), United Kingdom)
COI
2
Once- vs. twice-daily inhaled therapy in asthma: a network meta-analysis
J. Ora(Roma (RM), Italy)
COI
3
Budesoinde/formoterol: does eosinophil count cause different outcomes?
K. Dmytriiev(Edmonton, Canada)
COI
4
EFFECTS OF CYP3A5*3 ON ANTI-INFLAMATORY THERAPY IN CHILDREN WITH BRONCHIAL ASTHMA
A. Zastrozhina(Moscow, Russian Federation)
COI
5
Difficult-to-treat asthma : a multidimensional approach before considering targeted therapy
6
Airway hyperresponsiveness to mannitol improves in both type 2 low and type 2 high asthma after specialist management
M. Hvidtfeldt(Lejre, Denmark)
COI
7
Severe asthma registry program of Thailand (SARP-T) under multi-disciplinary care team Ramathibodi Hospital (A pilot study)
T. Kawamatawong(Bangkok, Thailand)
COI
8
QUALAS: QUAlity of Life and burden in ASthma, a comparison between uncontrolled severe asthma and controlled moderate/severe asthma
A. Bourdin(Montpellier Cedex 5, France)
COI
9
Gene expression of nociceptors in the esophagus of patients with gastro-esophageal reflux (GER)-associated chronic cough
N. Takeda(Nagoya, Japan)
COI
10
Mepolizumab as a steroid-sparing agent for eosinophilic granulomatosis with poliangiitis: a case series
S. Yamawaki(Tokyo, Japan)
COI
11
Mometasone furoate delivered via Breezhaler and Twisthaler in patients with asthma
R. Buhl(Mainz, Germany)
COI
12
Long-acting anti-muscarinic agents (LAMA) frequency of use and clinical features of patients with severe asthma in real-life setting: data from the Severe Asthma Network in Italy (SANI) registry
F. Puggioni(Rozzano (MI), Italy)
COI
13
Evaluation of urea as a normalization factor for nasosorption samples
R. Bauer(South San Francisco, United States)
COI
14
Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis
P. Rogliani(Roma (RM), Italy)
COI
15
Real-life inhaler technique in asthma patients using the electronic ProAir Digihaler
H. Chrystyn(Bingley (West Yorkshire), United Kingdom)
COI
16
Do seasons, in a warm temperate Mediterranean country, have an impact on asthma exacerbations?
A. Touil(Tunis, Tunisia)
COI
17
Late Breaking Abstract - Patterns of inhaled corticosteroid-formoterol prescriptions in Poland
R. Dobek(Warsaw, Poland)
COI
18
Late Breaking Abstract - Preliminary analysis of the data of patients with severe bronchial asthma included in the Russian National Register of Severe Asthma (RSAR)
N. Nenasheva(Moscow, Russian Federation)
COI
19
. . .
